Epidural Pain Management for Postoperative Pain
(PIBDOSE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine the optimal dose of a new pain relief method called Programmed Intermittent Epidural Bolus (PIEB) for individuals undergoing major abdominal surgery. The focus is on patients with large surgical incisions, as managing their pain can be challenging. Researchers will test different doses to assess if this method provides effective pain relief for both men and women. Ideal candidates for this trial are those planning to undergo open abdominal surgery with a large incision. As an unphased trial, this study offers participants the chance to contribute to innovative pain management solutions for future patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you use opioids daily, you cannot participate in the trial.
What prior data suggests that this method is safe for postoperative pain management?
Research shows that the programmed intermittent epidural bolus (PIEB) method is generally safe for managing post-surgical pain. Studies have found PIEB to be as effective and safe as other pain relief methods after major abdominal surgery. In these studies, patients experienced good pain control with fewer side effects, such as temporary muscle weakness.
One study showed that PIEB reduced the need for extra doctor visits by 6.9% compared to another method, suggesting it is well-tolerated. Another study found that PIEB provided effective pain relief with less muscle weakness after a cesarean section.
The medications used in PIEB, such as bupivacaine, fentanyl, and epinephrine, are commonly used in epidurals and are known to be safe when used correctly. While every treatment carries risks, existing research supports PIEB as a generally safe option for pain control after surgery.12345Why are researchers excited about this trial?
Researchers are excited about the programmed intermittent epidural bolus (PIEB) technique for postoperative pain management due to its potential to improve pain relief and patient comfort. Unlike traditional continuous epidural infusions, PIEB delivers controlled doses of anesthetics like bupivacaine, combined with fentanyl and epinephrine, at intervals, which can enhance the spread of medication and reduce motor block. This method might offer more consistent pain control while using less medication overall, potentially minimizing side effects and improving recovery experiences for patients after surgery.
What evidence suggests that this trial's treatments could be effective for postoperative pain management?
Studies have shown that Programmed Intermittent Epidural Bolus (PIEB) effectively manages post-surgical pain. PIEB offers better pain relief than continuous epidural infusion (CEI) and often reduces the need for additional pain medication. Research indicates that patients using PIEB report high satisfaction with their pain control. This trial will test different PIEB dosages to find the optimal dosage, with separate groups for male and female patients to explore any differences in effectiveness.26789
Who Is on the Research Team?
Veronique Brulotte, MD, MSc
Principal Investigator
Maisonneuve-Rosemont Hospital
Are You a Good Fit for This Trial?
This trial is for adults aged 18-85 with an ASA classification of I to III, who are undergoing open abdominal surgery and can have an epidural catheter placed. It's not suitable for those needing intensive care post-op, with coagulopathy, sepsis, local infection at the insertion site, daily opioid use or communication barriers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive programmed intermittent epidural bolus (PIEB) for postoperative analgesia after laparotomy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Programmed intermittent epidural bolus
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ciusss de L'Est de l'Île de Montréal
Lead Sponsor